LINCO-SPECTIN STERILE SOLUTION.

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Aktīvā sastāvdaļa:

LINCOMYCIN HYDROCHLORIDE, SPECTINOMYCIN SULFATE

Pieejams no:

Zoetis Ireland Limited

ATĶ kods:

QJ01FF52

SNN (starptautisko nepatentēto nosaukumu):

LINCOMYCIN HYDROCHLORIDE, SPECTINOMYCIN SULFATE

Deva:

50/100 Mg/Ml

Zāļu forma:

Solution for Injection

Receptes veids:

POM: Prescription Only Medicine as defined in relevant national legislation

Ārstniecības grupa:

Bovine, Canine, Feline, Porcine

Ārstniecības joma:

lincomycin, combinations

Ārstēšanas norādes:

Antibacterial

Autorizācija statuss:

Authorised

Autorizācija datums:

2013-12-09

Produkta apraksts

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Linco-Spectin Sterile Solution.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
A colourless to light yellow sterile solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs, non-ruminating calves, dogs and cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Linco-Spectin Sterile Solution is indicated for the treatment of
infections caused by organisms sensitive to the action of
lincomycin and / or spectinomycin including:
_Actinobacillus_ spp.
_Pasteurella_ spp.
_Serpulina hyodysenteriae_
_Escherichia coli_
_Salmonella_ spp.
_Campylobacter_ spp.
_Bacteroides_ spp.
_Clostridium_ spp.
_Fusobacterium_ spp.
_Actinomyces_ spp.
_Streptococcus_ spp.
_Mycoplasma_ spp.
Each ml contains:
Active Substance
Lincomycin (as lincomycin hydrochloride)
50
mg
Spectinomycin (as spectinomycin sulphate) 100 mg
Excipients
Benzyl alcohol
9
mg
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_0_
_/_
_1_
_2_
_/_
_2_
_0_
_1_
_3_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_5_
_6_
_0_
_6_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.3 CONTRAINDICATIONS
Do not use in animals previously found to be hypersensitive to either
active ingredient.
Do not
administer to rabbits,
hamsters,
guinea pigs,
chinchillas,
horses or ruminants as this could result
in severe
gastro-intestinal disturbance.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR